PRECISE-LAA provides additional evidence for a positive decisional impact of FEops HEARTguide
Now Study Results in the JACC Cardiovascular Interventions
FEops HEARTguide™ induces 33% DECISION CHANGE associated with:
➤ 98% Procedural success and 94.1% without residual leak
➤ No clinical complications at 6 weeks (98%) and at 1 year (100%)
FEops HEARTguide™ increases CONFIDENCE:
➤ Confidence level increased from 7 to 8 on a scale of 10*
*when no change in decision versus SoC
FEops HEARTguide™ positively impacts Abbott Amplatzer™ Amulet™ size selection in LAAO compared to TEE- and/or CT-based SoC assessment. Operators should consider FEops computational simulation in their preprocedural device size selection.
Decisional impact of CT-based 3D computational modeling in left atrial appendage occlusion: the PRECISE LAAO
The current study corroborates a positive decisional impact of FEops by inducing a correct device change in almost 1 of 3 patients compared to SoC in daily clinical practice. CT-based FEops simulation could be considered as the current standard in LAAO.
Decisional Impact of FEops on Device Size Selection
(A) Concordance between the preprocedural assessment techniques and the implanted device. (B) A Sankey diagram showing the decisional flow of the device selection induced by FEops.
Dr Ian Buysschaert and Dr Stijn Lochy at CSI Frankfurt 2023
PrepRocedural assEssment of anatomy and deviCe sIzing with CT and 3D Simulation in lEft atrial appendage occlusion:
the PRECISE LAAO Registry (NCT04640051)
Methods: Standard of Care as well as FEOPS-based assessments were compared in 102 consecutive patients scheduled for LAAO with Amulet in 6 different centers. Device size selection and degree of confidence (scale 1 to 10) were determined after SoC- and after FEOPS-based assessments, and compared to the implanted device
E-Poster CSI Education - CSI Frankfurt 2023 - Dr. Ian Buysschaert - AZ Sint Jan Bruges, Belgium